Ali Zarrinpar
University of Florida
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ali Zarrinpar as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06217094 · Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 TreatmentUniversity of Florida · withdrawn · Hepatocellular Carcinoma · principal investigator
- Ph2NCT05669339 · AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular CarcinomaUniversity of Florida · recruiting · Hepatocellular Carcinoma · principal investigator
- N/ANCT05432765 · AIIM Trial: Personalized Medicine Approach to Kidney Allograft FunctionUniversity of Florida · not yet recruiting · Kidney Transplant Rejection · principal investigator
- Ph2NCT04942665 · Low Dose ICG for Biliary Tract and Tumor ImagingUniversity of Florida · completed · Cholecystitis, Hepatocellular Carcinoma, Liver Metastases · principal investigator
- Ph2NCT03527238 · Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision MedicineUniversity of Florida · completed · Liver Transplant, Kidney Transplant · principal investigator
- N/ANCT02776111 · Microfluidics and Transcriptomics in Post Solid Organ Transplant PatientsUniversity of Florida · terminated · Immunosuppression · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Mentoring Patient-Oriented Research in Immune Response in TransplantationK24AI187634 · NIAID · UNIVERSITY OF FLORIDA · fiscal years 2025 to 2026 · $125,596 awarded in 2026Same name and institution; not confirmed by an ID
- Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion InjuryR01DK129690 · NIDDK · UNIVERSITY OF FLORIDA · fiscal years 2022 to 2025 · $569,158 awarded in 2025Same name and institution; not confirmed by an ID
- Ischemia-reperfusion injury in liver transplantationK08DK113244 · NIDDK · UNIVERSITY OF FLORIDA · fiscal years 2017 to 2021 · $154,764 awarded in 2021Same name and institution; not confirmed by an ID
- Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular CarcinomaUH3TR002087 · NCATS · UNIVERSITY OF FLORIDA · fiscal years 2020 · $152,462 awarded in 2020Same name and institution; not confirmed by an ID
- Optimizing Immunosuppression Drug Dosing via Phenotypic Precision MedicineR21DK116140 · NIDDK · UNIVERSITY OF FLORIDA · fiscal years 2018 to 2019 · $194,156 awarded in 2019Grant number is on one of their registry trials
- Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular CarcinomaUH2TR002087 · NCATS · UNIVERSITY OF FLORIDA · fiscal years 2017 to 2018 · $269,386 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:05 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.Am J Gastroenterol · 2017116 citationsRCR 5.5
- Aspiration therapy for the treatment of obesity: 4-year results of a multicenter randomized controlled trial.Surg Obes Relat Dis · 201937 citationsRCR 2.1
- Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial.Clin Gastroenterol Hepatol · 201535 citationsRCR 1.3
- Low vs Standard-Dose Indocyanine Green in the Identification of Biliary Anatomy Using Near-Infrared Fluorescence Imaging: A Multicenter Randomized Controlled Trial.J Am Coll Surg · 202324 citationsRCR 4.6
- 21 citationsRCR 1.0
- Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.Nat Commun · 202517 citationsRCR 6.4
- 5 citationsRCR 0.2
- Safety and Efficacy of Electromagnetic-Guided Bedside Placement of Nasoenteral Feeding Tubes versus Standard Placement.Am Surg · 20174 citationsRCR 0.3